Skip to main content
Log in

Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

We report the case of a young woman, with mixed connective tissue disease (MCTD), associated with disabling pulmonary hypertension and presence of the “lupus anticoagulant”. The “lupus anticoagulant”, an antibody directed against phospholipid components, was linked in our patient to extensive thrombophlebitis and premature labor. Raynaud's phenomenon progressed towards finger necrosis in spite of optimal vasodilating treatment. The part played by the “lupus anticoagulant” in pulmonary hypertension remains to be established. Both these complications responded to prednisolone therapy, but the improvement was limited and short-lived.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sharp, G.C., Irvin, W.S., Tan, E.M., Gould, R.G., Holman, H.R. Mixed connective-tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972, 52, 148–159.

    PubMed  Google Scholar 

  2. Alarcon-Segovia, D., Palacios, R. Human postthymic precursor cells in health and disease. IV. Abnormalities in immunoregulatory T cell circuits in mixed connective tissue disease. Arthritis Rheum 1981, 24, 1486–1494.

    PubMed  Google Scholar 

  3. Agia, G.A., Reddy, V.C., Maltby, J., Madigan, N.P., Sandock, K., Hurst, D.J. Pulmonary involvement in mixed connective tissue disease. Am Rev Resp Dis 1980, (suppl.) 121, 105–117.

    PubMed  Google Scholar 

  4. Esther, J.H., Sharp, G.C., Agia, G., Hurst, D.J. Pulmonary hypertension in patients with mixed connective tissue disease and antibody to nuclear ribonucleo-protein. Arthritis Rheum, 1981, 24, S 105.

    PubMed  Google Scholar 

  5. Grant, K.D., Adams, L.E., Hess, E.V. Mixed connective tissue disease, a subset with sequential clinical and laboratory features. J Rheumatol 1981, 8, 587–598.

    PubMed  Google Scholar 

  6. Rosenberg, A.M., Petty, R.E., Cumming, G.R., Koehler, B.E. Pulmonary hypertension in a child with mixed connective tissue disease. J Rheumatol 1979, 6, 700–704.

    PubMed  Google Scholar 

  7. Wiener-Kronish, J.P., Solinger, A.M., Warnock, M.L., Chrug, A., Ordonez, N., Golden, J.A. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Resp Dis 1981, 124, 499–503.

    PubMed  Google Scholar 

  8. Sullivan, W.D., Hurst, D.J., Harmon, C.E., Esther, J.H., Agia, G.A., Maltby, J.D., Lillard, S.B., Held, C.N., Wolfe, J.F., Sunderrajan, E.V., Maricq, H.R., Sharp, G.C. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 1984, 63, 92–107.

    PubMed  Google Scholar 

  9. Graziano, F.M., Friedman, L.C., Grossman, J. Pulmonary hypertension in a patient with mixed connective tissue disease: clinical and pathologic findings, and review of literature. Clin Exper Rheumatol 1983, 1, 251–255.

    Google Scholar 

  10. Manthorpe, R., Elling, H., Vandermeulen, J.T., Freiesleben Sörensen, S. Two fatal cases of mixed connective tissue disease. Scand J Rheumatol 1980, 9, 7–10.

    PubMed  Google Scholar 

  11. Singsen, B.H., Swanson, V.L., Bernstein, B.H., Heuser, E.T., Hanson, V., Landing, B.H. A histologic evaluation of mixed connective tissue disease in childhood. Am J Med 1980, 68, 710–717.

    PubMed  Google Scholar 

  12. Salerni, R., Rodnan, G.P., Leon, D.F., Shaver, J.A. Pulmonary hypertension in CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med 1977, 86, 394–399.

    PubMed  Google Scholar 

  13. Cryer, P.E., Kissans, J.M. Clinico-pathologic conference. Mixed connective tissue disease. Am J Med 1978, 65, 833–842.

    PubMed  Google Scholar 

  14. Jones, M.B., Osterholm, R.K., Wilson, R.B., Martin, F.H., Commers, J.R., Backmayer, J.D. Fatal pulmonary hypertension and resolving immune complex glomerulonephritis in mixed connective tissue disease: Case report and review of literature. Am J Med 1978, 65, 855–863.

    PubMed  Google Scholar 

  15. Elias, M., Eldor, A. Thromboembolism in patients with the “lupus” type circulating anticoagulant. Arch Intern Med 1984, 144, 510–515.

    PubMed  Google Scholar 

  16. Stranden, E., Roald, O.K., Krohg, K. Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin. Br Med J 1982, 285 1069–1071.

    Google Scholar 

  17. Rodeheffer, R.J., Rommer, J.A., Wigley, F., Smith, C.R. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 1983, 308, 880–883.

    PubMed  Google Scholar 

  18. Sharp, G.C. Mixed connective tissue disease — over-lap syndrome. Clin Rheum Dis 1975, 1, 561.

    Google Scholar 

  19. Prystowsky, S.D. Mixed connective tissue disease. West J Med 1980, 132, 288–293.

    PubMed  Google Scholar 

  20. Boxer, M., Ellman, L., Carvalho, A. The lupus anticoagulant. Arthritis Rheum 1976, 19, 1244–1248.

    PubMed  Google Scholar 

  21. Albert, J., Ekoe, J.M., Cunningham, M., Humair, L. Circulating anticoagulant in CREST syndrome. Br J Rheumatol 1984, 23, 20–23.

    PubMed  Google Scholar 

  22. Waddell, C.C., Brown, J.A. The lupus anticoagulant in 14 male patients. JAMA 1982, 248, 2493–2495.

    PubMed  Google Scholar 

  23. Soulier, J.P., Boffa, M.C. Avortements à répétition, thromboses et anticoagulant circulant antithromboplastine. Nouv Presse Med 1980, 9, 859–864.

    Google Scholar 

  24. Lechner, K. Acquired inhibitors in non-hemophilic patients. Haemostasis 1974, 3, 65–93.

    PubMed  Google Scholar 

  25. Mueh, J.R., Herbst, K.D., Rapaport, S.I. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980, 92, 156–159.

    PubMed  Google Scholar 

  26. Thiagarajan, P., Shapiro, S.S., Demarco, L. Monoclonal immunoglobulin M-lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 1980, 66, 397–405.

    PubMed  Google Scholar 

  27. Byron, M.A. The clotting defect in SLE. Clin Rheum Dis 1982, 8, 137–151.

    PubMed  Google Scholar 

  28. Exner, T., Rickard, K.A., Kronenberg, H. Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology 1975, 7, 319–328.

    PubMed  Google Scholar 

  29. Gladman, D.D., Urowitz, M.B. Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Ann Rheum Dis 1980, 39, 340–343.

    PubMed  Google Scholar 

  30. Boey, M.L., Colaco, C.B., Gharav, A.E., Elkon, K.B., Loizou, S., Hughes, G.R.V. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J 1983, 287, 1021–1023.

    Google Scholar 

  31. Angles-Cano, E., Sultan, Y., Clauvel, J.P. Predisposing factors to thrombosis in systemic lupus erythematosus. Possible relation to endothelial cell damage. J Lab Clin Med 1979, 94, 312–323.

    PubMed  Google Scholar 

  32. Schleider, M.A., Nachman, R.L., Jaffe, E.A., Co

  33. Carreras, L.O., Machin, S.J., Deman, R., Defreyn, G., Vermylen, J., Spitz, B., Vanassche, A. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of an immunoglobulin interfering with prostacyclin formation. Lancet 1981, 1, 244–246.

    PubMed  Google Scholar 

  34. Carreras, L.O., Vermylen, J., Spitz, B., Van Assche, A. Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981, 88, 890–894.

    PubMed  Google Scholar 

  35. Gardlund, B., The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus. Acta Med Scand 1984, 215, 293–298.

    PubMed  Google Scholar 

  36. Firkin, B.G., Howard, M.A., Radford, N. Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet 1980, 2, 366.

    Google Scholar 

  37. Hughes, G.R.V. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 1983, 287, 1088–1089.

    Google Scholar 

  38. Harris, E.N., Englert, H., Derue, G., Hughes, G.R.V., Gharavi, A. Antiphospholipid antibodies in acute Guillain-Barré syndrome. Lancet 1983, 2, 1361–1362.

    PubMed  Google Scholar 

  39. Seibold, J.R., Trontell, M.C. Anticentromere antibody and primary pulmonary hypertension. J Rheumatol 1982, 9, 607–609.

    PubMed  Google Scholar 

  40. Asherson, R.A., Mackworth-Young, C.G., Boey, M.L., Hull, R.G., Saunders, A., Gharavi, A.E., Hughes, G.R.V. Pulmonary hypertension in systemic lupus erythematosus. Br Med J 1983, 287, 1024–1025.

    Google Scholar 

  41. Walcott, G., Burchell, H.B., Brown, A.L. Primary pulmonary hypertension. Am J Med 1970, 49, 70–79.

    PubMed  Google Scholar 

  42. Fahey, P.J., Utell, M.J., Condemi, J.J., Green, R., Hyde, R.W. Raynaud's phenomenon of the lung. Am J Med 1984, 76, 263–269.

    PubMed  Google Scholar 

  43. Blunt, R.J., Porter, J.M. Raynaud syndrome. Semin Arthritis Rheum, 1981, 10, 282–308.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hainaut, P., Lavenne, E., Magy, J.M. et al. Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease. Clin Rheumatol 5, 96–101 (1986). https://doi.org/10.1007/BF02030976

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02030976

Key words

Navigation